ALPS Medical Breakthroughs ETF (SBIO) Stock Price, Quote, News & History

SBIOARCA

Trade with Public

$48.36

-1.54-3.09%

At close: Mar 27, 5:00 PM EST

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Sector

Healthcare

Region

AUM

126.27M

Fund Score

Key Statistics

Open

$49.67

High

$49.67

52 Wk High

$54.79

AUM

126.27M

Dividend

$0.62

Ex-Div Date

Dec 19, 2024

Volume

30.25K

Market Cap

$4.93B

Mgmt Fee

0.5%

P/E Ratio

20.68

Prev. Close

$49.90

Low

$48.35

52 Wk Low

$22.33

Shares Out

3.20M

Yield

1.23%

Div. Freq

Avg. Volume Daily

25.15K

Beta

0.80

Avg. Expense Ratio

0.5%

P/B Ratio

3.58

Recent ALPS Medical Breakthroughs ETF News

Structure Therapeutics Stock Explodes As Much-Awaited Experimental Oral Drug Trial Shows Weight Loss Of 16%

Structure Therapeutics' Phase 2 ACCESS II trial shows up to 16.3% placebo-adjusted weight loss for obesity drug aleniglipron.

Vandana Singh

Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index

Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ: CMPS) revealed Friday that it has been selected for addition to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective as of market open on Mon

Nina Zdinjak

Don't Bail On Biotech ETFs: 'There Are Several Reasons Why The Sector Took A Breather'

FAQ

How do I buy ALPS Medical Breakthroughs ETF (SBIO) stock?

You can purchase shares of ALPS Medical Breakthroughs ETF (ARCA:SBIO) through any online brokerage.

View our list of the best stock brokerages

Who are ALPS Medical Breakthroughs ETF (SBIO) competitors?

There are no as such competitors for ALPS Medical Breakthroughs ETF.

What is the forecast, or price target, for ALPS Medical Breakthroughs ETF (SBIO) stock?

There is no analysis for ALPS Medical Breakthroughs ETF to provide a consensus price target.

What is the current price for ALPS Medical Breakthroughs ETF (SBIO)?

The stock price for ALPS Medical Breakthroughs ETF (ARCA: SBIO) is $48.36 last updated March 27, 2026 at 8:00 PM EDT.

Does ALPS Medical Breakthroughs ETF (SBIO) pay a dividend?

There are no upcoming dividends for ALPS Medical Breakthroughs ETF.

When is ALPS Medical Breakthroughs ETF (ARCA:SBIO) reporting earnings?

ALPS Medical Breakthroughs ETF does not have any upcoming earnings scheduled.

Is ALPS Medical Breakthroughs ETF (SBIO) going to split?

There is no upcoming split for ALPS Medical Breakthroughs ETF.

Key Statistics

Open

$49.67

High

$49.67

52 Wk High

$54.79

AUM

126.27M

Dividend

$0.62

Ex-Div Date

Dec 19, 2024

Volume

30.25K

Market Cap

$4.93B

Mgmt Fee

0.5%

P/E Ratio

20.68

Prev. Close

$49.90

Low

$48.35

52 Wk Low

$22.33

Shares Out

3.20M

Yield

1.23%

Div. Freq

Avg. Volume Daily

25.15K

Beta

0.80

Avg. Expense Ratio

0.5%

P/B Ratio

3.58

About

Sector

N/A

Industry

N/A

ETF Details

Sector	Healthcare
Category	Mid Performer-Mid Growth
Investment Style	Small Cap Growth
Fund Inception	Dec 30, 2014
Managers	Ryan Mischke Charles Perkins
Definition	Most of the stocks in this equity fund have average financial performance and average growth potential

Investment Policy

The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

Top ETF Holdings

Symbol	Name	Share %
KYMR	Kymera Therapeutics In...	3.94%
CELC	Celcuity Inc Common St...	3.20%
IE	Alkermes Plc	3.62%
CRNX	Crinetics Pharmaceutic...	2.89%
ACAD	Acadia Pharmaceuticals...	2.63%
FOLD	Amicus Therapeutics In...	2.83%
MIRM	Mirum Pharmaceuticals ...	3.43%
GPCR	Structure Therapeutics...	3.17%
NAMS	Newamsterdam Pharma Co...	2.40%
CGON	Cg Oncology Inc	2.69%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Sector

Healthcare

Region

AUM

126.27M

Fund Score

Key Statistics

Open

$49.67

High

$49.67

52 Wk High

$54.79

AUM

126.27M

Dividend

$0.62

Ex-Div Date

Dec 19, 2024

Volume

30.25K

Market Cap

$4.93B

Mgmt Fee

0.5%

P/E Ratio

20.68

Prev. Close

$49.90

Low

$48.35

52 Wk Low

$22.33

Shares Out

3.20M

Yield

1.23%

Div. Freq

Avg. Volume Daily

25.15K

Beta

0.80

Avg. Expense Ratio

0.5%

P/B Ratio

3.58

FAQ

How do I buy ALPS Medical Breakthroughs ETF (SBIO) stock?

You can purchase shares of ALPS Medical Breakthroughs ETF (ARCA:SBIO) through any online brokerage.

View our list of the best stock brokerages

Who are ALPS Medical Breakthroughs ETF (SBIO) competitors?

There are no as such competitors for ALPS Medical Breakthroughs ETF.

What is the forecast, or price target, for ALPS Medical Breakthroughs ETF (SBIO) stock?

There is no analysis for ALPS Medical Breakthroughs ETF to provide a consensus price target.

What is the current price for ALPS Medical Breakthroughs ETF (SBIO)?

The stock price for ALPS Medical Breakthroughs ETF (ARCA: SBIO) is $48.36 last updated March 27, 2026 at 8:00 PM EDT.

Does ALPS Medical Breakthroughs ETF (SBIO) pay a dividend?

There are no upcoming dividends for ALPS Medical Breakthroughs ETF.

When is ALPS Medical Breakthroughs ETF (ARCA:SBIO) reporting earnings?

ALPS Medical Breakthroughs ETF does not have any upcoming earnings scheduled.

Is ALPS Medical Breakthroughs ETF (SBIO) going to split?

There is no upcoming split for ALPS Medical Breakthroughs ETF.

Key Statistics

Open

$49.67

High

$49.67

52 Wk High

$54.79

AUM

126.27M

Dividend

$0.62

Ex-Div Date

Dec 19, 2024

Volume

30.25K

Market Cap

$4.93B

Mgmt Fee

0.5%

P/E Ratio

20.68

Prev. Close

$49.90

Low

$48.35

52 Wk Low

$22.33

Shares Out

3.20M

Yield

1.23%

Div. Freq

Avg. Volume Daily

25.15K

Beta

0.80

Avg. Expense Ratio

0.5%

P/B Ratio

3.58

About

Sector

N/A

Industry

N/A

ETF Details

Sector	Healthcare
Category	Mid Performer-Mid Growth
Investment Style	Small Cap Growth
Fund Inception	Dec 30, 2014
Managers	Ryan Mischke Charles Perkins
Definition	Most of the stocks in this equity fund have average financial performance and average growth potential

Investment Policy

Top ETF Holdings

Symbol	Name	Share %
KYMR	Kymera Therapeutics In...	3.94%
CELC	Celcuity Inc Common St...	3.20%
IE	Alkermes Plc	3.62%
CRNX	Crinetics Pharmaceutic...	2.89%
ACAD	Acadia Pharmaceuticals...	2.63%
FOLD	Amicus Therapeutics In...	2.83%
MIRM	Mirum Pharmaceuticals ...	3.43%
GPCR	Structure Therapeutics...	3.17%
NAMS	Newamsterdam Pharma Co...	2.40%
CGON	Cg Oncology Inc	2.69%